Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ISRCTN15647953) titled 'A research study testing whether a single dose of [18F]AldoView can produce useful images of adrenal glands allowing identification of participants with and without primary aldosteronism' on April 20.
Study Type: Observational
Study Design:
Case-control study
Primary Sponsor: University College London
Condition:
Primary aldosteronism
Nutritional, Metabolic, Endocrine
Intervention:
All participants receive a single intravenous bolus injection of [18F]AldoView as a sterile injectable solution at a dose of 200 ± 20 MBq (up to and including 10 micrograms non-radioactive compound).
The tri...